At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Xenogeneic Collagen Matrix +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled Clinical Trial to Evaluate a Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation
In Brief
A clinical study evaluating Xenogeneic Collagen Matrix and Free Gingival Graft for Gingival Diseases. Completed, enrolled 30 participants.
Detailed Summary
A split-mouth study comparing soft tissue augmentation results using free gingival graft (FGG) versus xenogeneic collagen matrix (CM) for the generation of keratinized tissue (KT) around teeth with insufficient (\< 2mm) KT.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingival Diseases
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
Primary CompletionOct 2011
Study CompletionJan 2012
First PostedSep 2013
TodayJul 2026
First PostedSep 27, 2013
Enrollment StartNov 1, 2010
Primary CompletionOct 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.8 years ago
Interventions
Xenogeneic Collagen Matrixdevice
A type I and III porcine collagen matrix, as cleared by FDA (K012423)
Free Gingival Graftdevice
Autogenous, full-thickness soft tissue graft harvested from patient's palate.